Clinical Trials Browser

Unknown × blinatumomab × Clear all

NCT06125106 2023-11-09

Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06075212 2023-10-10

Immune Reconstitution After Allo-HSCT and Blinatumomab

Other hematologic neoplasm

Leukemia, Lymphoid

NCT03318770 2022-10-12

Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05559450 2022-09-29

Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL

Phase 2 Unknown

Burkitt Lymphoma

NCT04604691 2022-03-08

Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD)

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04334993 2021-05-07

Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study

Phase 2 Unknown

Philadelphia-Negative ALL

NCT04723342 2021-01-25

Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot

Phase NA Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02744768 2018-03-22

D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma